Vorsetuzumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5992
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Vorsetuzumab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
CD70ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P32970
Shipping Conditions
Blue ice
Background
CD70 is the ligand for CD27 and a costimulatory molecule overexpressed on several tumors, making it a target of interest in immuno-oncology research. Provided as an unconjugated, non-therapeutic analog of vorsetuzumab, this recombinant human IgG1 antibody binds CD70 and is supplied for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo studies and manufactured in scalable milligram to gram quantities for high-throughput and heavy-usage laboratories. The antibody supports antigen-binding and internalization assays, in vitro screening, control work, ADCC studies, and preclinical targeted-therapy and ADC development models.
Other Names
CD27LG, TNFSF7
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Vorsetuzumab Biosimilar - Research Grade
Your Rating
Back to Top